n-methyl-3,4-methylenedioxyamphetamine has been researched along with Choroid Diseases in 2 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Choroid Diseases: Disorders of the choroid including hereditary choroidal diseases, neoplasms, and other abnormalities of the vascular layer of the uvea.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Michael, JC | 1 |
| Pak, J | 1 |
| Pulido, J | 1 |
| de Venecia, G | 1 |
| Hassan, L | 1 |
| Carvalho, C | 1 |
| Yannuzzi, LA | 1 |
| Iida, T | 1 |
| Negrão, S | 1 |
2 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Choroid Diseases
| Article | Year |
|---|---|
Central serous chorioretinopathy associated with administration of sympathomimetic agents.
Topics: Adult; Choroid Diseases; Ephedrine; Female; Fluorescein Angiography; Humans; Male; N-Methyl-3,4-meth | 2003 |
Central serous chorioretinopathy in a patient using methylenedioxymethamphetamine (MDMA) or "ecstasy".
Topics: Adrenergic Uptake Inhibitors; Adult; Choroid Diseases; Exudates and Transudates; Humans; Male; N-Met | 2001 |